News | Magnetic Resonance Imaging (MRI) | February 24, 2021

SpinTech Acquires MR Innovations

Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations).

February 24, 2021 — Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations). The acquisition brings an expert team of Ph.D. and master's-level engineers and physicists and also includes MR Innovations' 10 patents, over 300 published papers and a network of more than 50 global collaborators.

To honor the legacy of MR Innovations, the company, which currently does business under the name SpinTech Imaging, will rebrand to use the name SpinTech MRI.

"Our goal has always been to push the boundaries of what's possible with MRI while delivering practical solutions for the benefit of clinicians and patients along the way," said company CEO Ward Detwiler. "With the acquisition of MR Innovations, we're able to better pioneer the forefront of MRI technology while continually improving the present."

Joining SpinTech to provide fully-integrated research and development, MR Innovations also brings its expertise in protocol development for medical imaging scans, image processing services, clinical research organization consulting, and innovation in imaging hardware and software. "We are thrilled to provide end-to-end technology development for our MRI partners, radiologists, neurologists and researchers through this acquisition," said Detwiler.

In the past, MR Innovations and SpinTech have worked closely to create innovative technology for products such as STAGE, a standardized MRI software program allowing for improved efficiency and AI-assisted detection. STAGE technology allows for up to 40% faster MRI acquisition times for brain scans, improved visualization, and quantitative results with applications across conditions such as Parkinson's disease, dementia, traumatic brain injury, multiple sclerosis and stroke.

"With the expertise of our MR Innovations team members," said Founder and Chief Science Officer, E. Mark Haacke, Ph.D., "SpinTech MRI will now see medical imaging software production from base research to clinical deployment, continuing to lead MRI technology development with revolutionary ideas realized through fully supported software and products."

For more information: spintechimaging.com

Related Content

CDC and FDA Call for Pause on Janssen COVID-19 Vaccine Due to Rare Blood Clots #COVID19 #Janssen
Feature | Coronavirus (COVID-19) | April 15, 2021 | By Dave Fornell
April 15, 2021 — The U.S.
#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business | April 15, 2021
April 15, 2021 — Siemens Healthineers AG an
Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

News | Breast Imaging | April 14, 2021
April 14, 2021 — Detecting and analyzing breast cancer
A doctor reading #CXR scans using #SenseCare-Chest #DR Pro #diagnostic #software.

A doctor reading CXR scans using SenseCare-Chest DR Pro diagnostic software.

News | Artificial Intelligence | April 14, 2021
April 14, 2021 — SenseTime, a world-leading...
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | April 09, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine scr
IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 09, 2021
April 9, 2021 — According to an open-acc...
Futuristic campus design of Siemens Healthineers in Bengaluru, India.

Futuristic campus design of Siemens Healthineers in Bengaluru, India.

News | Radiology Business | April 08, 2021
April 8, 2021 — Siemens Healthineers announced t